DNLIDenali Therapeutics Inc.

$18.41+10% 1Y

Is the price fair?

What DNLI's price assumes

Price / book
5.77

Price / book · as of 2026-Q2

Details›
Price / bookas of 2026-Q2
5.77
Market capitalisation159.8 million shares, counted Jul 31, 2026
$2.94B

Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.